Department of Family Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Geriatric Medicine, National Yang Ming Chiao Tung University, School of Medicine, Taipei, Taiwan; Department of Family Medicine, Taipei Veterans General Hospital Yuanshan Branch, Yi-Lan County, Taiwan.
J Nutr Health Aging. 2024 Jun;28(6):100268. doi: 10.1016/j.jnha.2024.100268. Epub 2024 May 28.
BACKGROUND: Sarcopenia and intrinsic capacity (IC) declines pose significant challenges to healthy aging, particularly in the rapidly growing octogenarian population. This study aimed to elucidate the relationship between sarcopenia and declines in IC across multiple cohorts of community-dwelling older adults. METHODS: Data from four Taiwanese cohorts were analyzed. Sarcopenia was diagnosed based on the Asian Working Group for Sarcopenia (AWGS) 2019 criteria (algorithm 1: categorized as either having possible sarcopenia or not (robust); algorithm 2: categorized as robust, possible sarcopenia or sarcopenia). IC was operationalized using the World Health Organization's Integrated Care for Older People (ICOPE) framework (step 1 and step 2), encompassing six domains: locomotion, vitality, vision, hearing, cognition, and psychological well-being. Multivariable logistic regression models were adopted to assess the association between sarcopenia and IC decline. RESULTS: Among 599 octogenarians (median age 82.2 years, 54.8% male), the prevalence of possible sarcopenia (algorithm 1) was 64.6%. When adopting algorithm 2, the prevalence of possible sarcopenia and sarcopenia was 46,2% and 32.1%, respectively. After adjusting for covariates, participants with possible sarcopenia or sarcopenia (algorithm 2) were more likely to exhibit declines in vitality (ICOPE Step 1: possible sarcopenia aOR 3.65, sarcopenia aOR 4.74; ICOPE Step 2: possible sarcopenia aOR 5.11, sarcopenia aOR 14.77) and cognition (ICOPE Step 1: possible sarcopenia aOR 2.40, sarcopenia aOR 2.12; ICOPE Step 2: possible sarcopenia aOR 2.02, sarcopenia aOR 2.51) compared to robust individuals. CONCLUSIONS: This study underscores the robust association between sarcopenia and declines in vitality and cognition among octogenarians, highlighting the importance of sarcopenia screening and management in promoting healthy longevity in this vulnerable population.
背景:肌少症和内在能力(IC)下降对健康老龄化构成重大挑战,特别是在快速增长的 80 岁以上人群中。本研究旨在阐明肌少症与多个社区居住的老年人队列中 IC 下降之间的关系。
方法:分析了来自四个台湾队列的数据。根据亚洲肌少症工作组(AWGS)2019 标准(算法 1:归类为存在或不存在可能的肌少症(稳健);算法 2:归类为稳健、可能的肌少症或肌少症)诊断肌少症。内在能力使用世界卫生组织的老年人综合护理(ICOPE)框架(步骤 1 和步骤 2)来操作,包括六个领域:运动、活力、视力、听力、认知和心理健康。采用多变量逻辑回归模型评估肌少症与 IC 下降之间的关联。
结果:在 599 名 80 岁老年人中(中位年龄 82.2 岁,54.8%为男性),可能的肌少症(算法 1)的患病率为 64.6%。采用算法 2 时,可能的肌少症和肌少症的患病率分别为 46.2%和 32.1%。调整协变量后,可能的肌少症或肌少症(算法 2)患者活力(ICOPE 步骤 1:可能的肌少症 aOR 3.65,肌少症 aOR 4.74;ICOPE 步骤 2:可能的肌少症 aOR 5.11,肌少症 aOR 14.77)和认知(ICOPE 步骤 1:可能的肌少症 aOR 2.40,肌少症 aOR 2.12;ICOPE 步骤 2:可能的肌少症 aOR 2.02,肌少症 aOR 2.51)下降的可能性高于稳健个体。
结论:本研究强调了肌少症与 80 岁以上人群活力和认知下降之间的密切关系,凸显了肌少症筛查和管理在促进这一脆弱人群健康长寿方面的重要性。
J Gerontol A Biol Sci Med Sci. 2024-7-1
Physiol Rev. 2025-7-1